Several days after many nations paushed the use of Oxford/AstraZeneca's vaccine - which Malawi is also administering - over blood clot concerns, European Medicines Agency has concluded that the vaccine is "safe and effective "in preventing Covid-19 and its benefits far outweigh the risks.
The EU medicines regulator said the safety committee PRAC concluded the vaccine is "not associated with an increase in the overall risk of thromboembolic events or blood clots."
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article